Suchergebnisse - "Carr, Daniel J"

PubPharm (208)

1

Complement Suppresses the Initial Type 1 Interferon Response to Ocular Herpes Simplex Virus Type 1 Infection in Mice

enthalten in: Pathogens (Basel, Switzerland) | 2024

von Carr, D. | Filiberti, A. | Gmyrek, G.

2

Using web analytics data to identify platforms and content that best engage high-priority HIV populations in online and social media marketing advertisements

enthalten in: Digital health | 2023

von Wray, T. | Chan, P. | Klausner, J. | +6

3

HSV-1 0∆NLS vaccine elicits a robust B lymphocyte response and preserves vision without HSV-1 glycoprotein M or thymidine kinase recognition

enthalten in: Scientific reports | 2022

von Gmyrek, G. | Berube, A. | Sjoelund, V. | +1

4

Noncognate Signals Drive Enhanced Effector CD8+ T Cell Responses through an IFNAR1-Dependent Pathway after Infection with the Prototypic Vaccine, 0ΔNLS, against Herpes Simplex Virus 1

enthalten in: Journal of virology | 2022

von Gmyrek, G. | Predki, P. | Gershburg, E. | +1

5

Tripartite-Motif 21 (TRIM21) Deficiency Results in a Modest Loss of Herpes Simplex Virus (HSV)-1 Surveillance in the Trigeminal Ganglia Following Cornea Infection

enthalten in: Viruses | 2022

von Berube, A. | Gmyrek, G. | Royer, D. | +1

6

Osteopontin contributes to virus resistance associated with type I IFN expression, activation of downstream ifn-inducible effector genes, and CCR2+CD115+CD206+ macrophage infiltration following ocular HSV-1 infection of mice

enthalten in: Frontiers in immunology | 2022

von Filiberti, A. | Gmyrek, G. | Berube, A. | +1

7

The Durability of Vaccine Efficacy against Ocular HSV-1 Infection Using ICP0 Mutants 0∆NLS and 0∆RING Is Lost over Time

enthalten in: Pathogens (Basel, Switzerland) | 2021

von Carr, D. | Berube, A. | Gershburg, E.

8

The Chx10-Traf3 Knockout Mouse as a Viable Model to Study Neuronal Immune Regulation

enthalten in: Cells | 2021

von Gurley, J. | Gmyrek, G. | Hargis, E. | +3

9

An intact complement system dampens cornea inflammation during acute primary HSV-1 infection

enthalten in: Scientific reports | 2021

von Filiberti, A. | Gmyrek, G. | Berube, A. | +2

10

Lack of neonatal Fc receptor does not diminish the efficacy of the HSV-1 0ΔNLS vaccine against ocular HSV-1 challenge

enthalten in: Vaccine | 2021

von Carr, D. | Berube, A. | Filiberti, A. | +1

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[21]